Literature DB >> 23784841

Role of epigenetics in the etiology of germ cell cancer.

Yvonne G Van Der Zwan1, Hans Stoop, Fernando Rossello, Stefan J White, Leendert H J Looijenga.   

Abstract

Embryonic development is strictly controlled by functionality of genes in which the existing networks can act both on transcription and translation regulation. Germ cell cancers (GCC) are unique because of a number of characteristics. In spite of their clinical presentation, i.e., predominantly after puberty, they arise from primordial germ cells/gonocytes that have failed appropriate maturation to either pre-spermatogonia or oogonia. GCC mimic embryonal development to a certain extent, including capacity for totipotency. This knowledge has allowed the identification of informative diagnostic markers, including OCT3/4 (POU5F1), SOX2 and SOX17. An additional marker is the overall demethylated status of the genome. Genetic mutations in GCC are rare, which is exceptional for solid cancers. Our hypothesis is that a disturbed epigenetic regulation (through combined interaction of genetic or environmental parameters; referred to as genvironment) affect embryonic germ cell development, resulting in delayed or blocked maturation, and potentially progression to GCC. In this respect, studies of patients with Disorders of Sex Development (DSD) have increased our knowledge significantly. Genvironmental influences can lead to retention of existence of embryonic germ cells, the first step in the pathogenesis of GCC, resulting into the precursor lesions gonadoblastoma or carcinoma in situ. Identification of epigenetic alterations could lead to better understanding these processes and development of specific markers for early detection, eventually leading to development of targeted treatment. This review describes an interactive model related to the role of epigenetics in GCC pathogenesis, focusing on DNA methylation, histone modifications, epigenetic memory and inheritance, as well as environmental factors.

Entities:  

Mesh:

Year:  2013        PMID: 23784841     DOI: 10.1387/ijdb.130017ll

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  17 in total

Review 1.  A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.

Authors:  Louise C Pyle; Katherine L Nathanson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-05-25       Impact factor: 3.908

2.  Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors.

Authors:  Martin A Rijlaarsdam; David M J Tax; Ad J M Gillis; Lambert C J Dorssers; Devin C Koestler; Jeroen de Ridder; Leendert H J Looijenga
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

Review 3.  Mechanisms Regulating Stemness and Differentiation in Embryonal Carcinoma Cells.

Authors:  Gregory M Kelly; Mohamed I Gatie
Journal:  Stem Cells Int       Date:  2017-03-08       Impact factor: 5.443

4.  Meta-Analysis of Gene Expressions in Testicular Germ Cell Tumor Histologies.

Authors:  Finn Edler von Eyben; Jorge Parraga-Alava
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

5.  The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays.

Authors:  Daniela C F Salvatori; Lambert C J Dorssers; Ad J M Gillis; Gemma Perretta; Ton van Agthoven; Maria Gomes Fernandes; Hans Stoop; Jan-Bas Prins; J Wolter Oosterhuis; Christine Mummery; Leendert H J Looijenga
Journal:  Stem Cell Reports       Date:  2018-11-29       Impact factor: 7.765

Review 6.  The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors.

Authors:  João Lobo; Daniela Barros-Silva; Rui Henrique; Carmen Jerónimo
Journal:  Genes (Basel)       Date:  2018-11-13       Impact factor: 4.096

7.  c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors.

Authors:  Katia Corano Scheri; Erica Leonetti; Luigi Laino; Vincenzo Gigantino; Luisa Gesualdi; Paola Grammatico; Mariano Bizzari; Renato Franco; J Wolter Oosterhuis; Hans Stoop; Leendert H J Looijenga; Giulia Ricci; Angela Catizone
Journal:  Oncotarget       Date:  2018-08-07

8.  DMRforPairs: identifying differentially methylated regions between unique samples using array based methylation profiles.

Authors:  Martin A Rijlaarsdam; Yvonne G van der Zwan; Lambert C J Dorssers; Leendert H J Looijenga
Journal:  BMC Bioinformatics       Date:  2014-05-15       Impact factor: 3.169

9.  Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines.

Authors:  Yvonne G van der Zwan; Martin A Rijlaarsdam; Fernando J Rossello; Amanda J Notini; Suzan de Boer; D Neil Watkins; Ad J M Gillis; Lambert C J Dorssers; Stefan J White; Leendert H J Looijenga
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

10.  Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice.

Authors:  Paul B Comish; Ana Luiza Drumond; Hazel L Kinnell; Richard A Anderson; Angabin Matin; Marvin L Meistrich; Gunapala Shetty
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.